Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector

9 Apr 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Virology and Viral Diseases
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18396306
DOI: 10.1016/j.virol.2008.03.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vectorPMID 18396306Read ↗

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vectorSemantic proximity Read ↗

An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus RecombinantsSemantic proximity Read ↗

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessmentSemantic proximity Read ↗

Vectored vaccines to protect against PRRSVSemantic proximity Read ↗

A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoVSemantic proximity Read ↗

Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunizationSemantic proximity Read ↗

Vaccines against pseudorabies virus (PrV)Semantic proximity Read ↗

Production and characterization of vaccines based on flaviviruses defective in replicationSemantic proximity Read ↗

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidateSemantic proximity Read ↗

Pros and Cons of Adenovirus-Based SARS-CoV-2 VaccinesSemantic proximity Read ↗

A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challengeSemantic proximity Read ↗

A Single-Cycle Vaccine Vector Based on Vesicular Stomatitis Virus Can Induce Immune Responses Comparable to Those Generated by a Replication-Competent VectorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.